adjuvant

(redirected from Adjuvant treatment)
Also found in: Dictionary, Thesaurus, Medical, Legal.
Related to Adjuvant treatment: palliative treatment

adjuvant

[′aj·ə·vənt]
(pharmacology)
A material that enhances the action of a drug or antigen.
Mentioned in ?
References in periodicals archive ?
However, in Europe adjuvant chemotherapy currently remains the standard of care for adjuvant treatment in R0/R1 resected pancreatic cancer: recent trials could not establish any benefit from adding radiation to chemotherapy, and its value in this context still remains an open question.
Treatment of gastric and pancreatic cancers
Women with breast cancer do not consistently receive adjuvant treatments that have been shown to increase survival.
Some women with breast cancer do not receive adjuvant treatments recommended by guidelines
Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment.
Angiogenesis and breast cancer
Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A; Multicenter International Study of Oxaliplatin/5-Fluorouracil/ Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators.
Stage III colon cancer at Baylor University Medical Center at Dallas and the Baylor Sammons Cancer Center: experience from 2000 to 2004
Last month, Pfizer received approval for adjuvant treatment in the
PFIZER INC - Regulatory Approval
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
Women & living with breast cancer today
In the cases where cancer has spread from the breast into the lymphatic system, more effective adjuvant treatment is now being used in clinical trials.
Key to beating breast cancer is in our hands; Self-screening is vital to keep death toll down
NeuVax targets the remaining 50% of HER2 positive patients (HER2 1+ and 2+) who achieve remission with current standard of care, but have no available HER2 targeted adjuvant treatment options to maintain their disease free status.
RXi Pharmaceuticals Presents Additional Positive Phase 2 Efficacy Results for Combination of NeuVaxTM (E75) and Trastuzumab Breast Cancer at ASCO
The Company's lead product candidate is an investigational drug known as PB272 ("neratinib"), which the Company had touted as an extended adjuvant treatment of human epidermal growth factor receptor 2 ("HER2")-positive metastatic breast cancer.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI
The randomized, double-blind, placebo-controlled Phase III trial is evaluating regorafenib as an adjuvant treatment of colorectal cancer following resection of liver metastases with curative intent.
Germany : Phase III Trial of Regorafenib Shows Insufficient Patient Recruitment
5 percent of patients had one or more CTC in their blood before the start of adjuvant treatment.
Circulating tumour cells in blood up death risk in early-stage breast cancer patients
Targeting insulin as a therapeutic modality in breast cancer could be an option in the adjuvant treatment of breast cancer.
Journal abstracts: is it the time for metformin to take place in adjuvant treatment of Her-2 positive breast cancer? Teaching new tricks to old dogs

Encyclopedia browser ?
Full browser ?